Digital science and knowledge boundaries in complex innovation

Organization Science

Volumn 23, Issue 5, 2012, Pages 1467-1484

  Dougherty, Deborah ^a   Dunne, Danielle D ^b  

^a RUTGERS UNIVERSITY   (United States)

^b FORDHAM UNIVERSITY   (United States)

Author keywords

Organizational processes; Organizing for innovation; Technology and innovation

Indexed keywords

EID: 84872529949     PISSN: 10477039     EISSN: 15265455     Source Type: Journal    
DOI: 10.1287/orsc.1110.0700     Document Type: Article

References (48)

1. Barley, S. R. 1986. Technology as an occasion for structuring: Evidence from observations of CT scanners and the social order of radiology departments. Admin. Sci. Quart. 31(1) 78-108.
2. Barry, A. 2005. Pharmaceutical matters: The invention of informed materials. Theory, Culture Soc. 22(1) 51-69.
3. Bechky, B. A. 2003. Sharing meaning across organizational communities: The transformation of understanding on a production floor. Organ. Sci. 14(3) 312-330.
4. Boisot, M., B. McKelvey. 2010. Integrating modernist and postmodernist perspectives in organizations: A complexity science bridge. Acad. Management Rev. 35(3) 415-433.
5. Boland, R. J., Jr., K. Lyytinen, Y. Yoo. 2007. Wakes of innovation in project networks: The case of digital 3-D representations in architecture, engineering, and construction. Organ. Sci. 18(4) 631-647.
6. Brown, S. L., K. M. Eisenhardt. 1997. The art of continuous change: Linking complexity theory and time-paced evolution in relentlessly shifting organizations. Admin. Sci. Quart. 42(1) 1-34.
7. Burns, L. R., ed. 2005. The Business of Healthcare Innovation. Cambridge University Press, New York.
8. Carlile, P. R. 2004. Transferring, translating, and transforming: An integrative framework for managing knowledge across boundaries. Organ. Sci. 15(5) 555-568.
9. Cohen, J. 2011. The human genome, a decade later. Tech. Rev. 114(1) 40-56.
10. Cooper, R. G. 1998. Product Leadership: Creating and Launching Superior New Products. Perseus Books, Reading MA.
11. Dodgson, M., D. M. Gann, A. Salter. 2007. "In case of fire, please use the elevator": Simulation technology and organization in fire engineering. Organ. Sci. 18(5) 849-864.
12. Dougherty, D. 1992. Interpretive barriers to successful product innovation in large firms. Organ. Sci. 3(2) 179-202.
13. Dougherty, D. 2002. Grounded theory research methods. J. A. C. Baum, ed. The Blackwell Companion to Organizations. Blackwell, London, 849-866.
14. Gavetti, G., D. Levinthal. 2000. Looking forward and looking backward: Cognitive and experiential search. Admin. Sci. Quart. 45(1) 113-137.
15. Grandori, A. 2010. A rational heuristic model of economic decision making. Rationality Soc. 22(4) 477-504.
16. Khurana, A., S. R. Rosenthal. 1997. Integrating the fuzzy front end of new product development. MIT Sloan Management Rev. 38(2) 103-120.
17. Knorr-Cetina, K. 1999. Epistemic Cultures: How the Sciences Make Knowledge. Harvard University Press, Cambridge, MA. Lave, J., E. Wenger. 1991. Situated Learning: Legitimate Peripheral Participation. Cambridge University Press, Cambridge, UK.
18. Leonard-Barton, D. 1995. Wellsprings of Knowledge: Building and Sustaining the Sources of Innovation. Harvard Business Press, Cambridge, MA.
19. Levina, N., E. Vaast. 2005. The emergence of boundary spanning competence in practice: Implications for implementation and use of information systems. MIS Quart. 29(2) 335-363.
20. Luther, M. 2009. Opportunities at the public-private interface. Presentation, 5th Annual BioSciences Forum, October 30, North Carolina State University, Research Triangle Park.
21. Majchrzak, A., D. Logan, R. McCurdy, M. Kirchmer. 2006. Four keys to managing emergence. MIT Sloan Management Rev. 27(2) 14-18.
22. March, J. G. 1991. Exploration and exploitation in organizational learning. Organ. Sci. 2(1) 71-87.
23. Ng, R. 2004. Drugs: From Discovery to Approval. John Wiley & Sons, Hoboken, NJ.
24. Nightingale, P. 1998. A cognitive model of innovation. Res. Policy 27(7) 689-709.
25. Northrup, J. 2005. The pharmaceutical sector. L. R. Burns, ed. The Business of Healthcare Innovation. Cambridge University Press, New York, 27-102.
26. Orlikowski, W. J. 2002. Knowing in practice: Enacting a collective capability in distributed organizing. Organ. Sci. 13(3) 249-273.
27. Patwardhan, B., A. D. B. Vaidya, M. Chorghade, S. P. Joshi. 2008. Reverse pharmacology and systems approaches for drug discovery and development. Curr. Bioactive Compounds 4(4) 201-212.
28. Pickering, A. 1995. The Mangle of Practice: Time, Agency, and Science. University of Chicago Press, Chicago.
29. Peirce, C. 1935. The Collected Papers of Charles Sanders Peirce, Vol. 5. Edited by C. Hartshorne, P. Weiss. Harvard University Press, Cambridge, MA.
30. Pisano, G. P. 2006. Science Business: The Promise, the Reality, and the Future of Biotech. Harvard Business School Press, Boston.
31. Sammut, S. M. 2005. Biotechnology business and revenue models: The dynamic of technological evolution and capital market ingenuity. L. R. Burns, ed. The Business of Healthcare Innovation. Cambridge University Press, New York, 190-222.
32. Sennett, R. 2008. The Craftsman. Yale University Press, New Haven, CT.
33. Simon, H. A. 1977. Models of Discovery and Other Topics in the Methods of Science. D. Reidel Publishing, Dordrecht, Holland.
34. Simon, H. A. 1996. The Sciences of the Artificial, 3rd ed. MIT Press, Cambridge, MA.
35. Singer, E. 2009. Interpreting the genome. Tech. Rev. 112(1) 48-53.
36. Snowden, D. J., M. E. Boone. 2007. A leader's framework for decision making. Harvard Bus. Rev. 85(11) 68-76.
37. Southan, C., G. Cameron. 2009. Beyond the tsunami: Developing the infrastructure to deal with life sciences data. T. Hey, S. Tansley, K. Tolle, eds. The Fourth Paradigm: Data-Intensive Scientific Discovery. Microsoft Research, Redmond, WA, 117-123.
38. Strauss, A. L. 1987. Qualitative Analysis for Social Scientists. Cambridge University Press, Cambridge, UK.
39. Strauss, A., J. Corbin. 1998. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory, 2nd ed. Sage, Thousand Oaks, CA.
40. Suchman, L. 1987. Plans and Situated Actions: The Problem of Human Machine Communication. Cambridge University Press, Cambridge, UK.
41. Turro, N. J. 1986. Geometric and topological thinking in organic chemistry. Angew. Chem. Internat. Ed. 25(10) 882-901.
42. Ulrich, K. T., S. D. Eppinger. 2000. Product Design and Development. Irwin McGraw-Hill, Boston.
43. U.S. Food and Drug Administration. 2004. Innovation or stagnation: Challenge and opportunity on the critical path to new medical products. Report, U.S. Health and Human Services, Washington, DC.
44. Van de Ven, A. H., D. E. Polley, R. Garud, S. Venkataraman. 1999. The Innovation Journey. Oxford University Press, New York.
45. Wishart, D. S. 2008. Applications of metabolomics in drug discovery and development. Drug R&D 9(5) 307-322.
46. Yang, D. J., E. E. Kim. 2008. Imaging science and technology in drug discovery. Current Medical Imaging Rev. 4(1) 1-1.
47. Yoo, Y., O. Henfridsson, K. Lyytinen. 2010a. The new organizing logics of digital innovation: An agenda for information systems research. Inform. Systems Res. 21(4) 724-735.
48. Yoo, Y., K. J. Lyytinen, R. J. Boland Jr., N. Berente. 2010b. The next wave of digital innovation: Opportunities and challenges, A report on the research workshop "Digital challenges in innovation research." Working paper, Temple University, Philadelphia. http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1622170.